VanEck Vectors Biotech ETF (BBH)

Delayed Data
As of 2:45pm ET
 -1.75 / -1.50%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to replicate as closely as possible- before fees and expenses- the price and yield performance of the MVIS- US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology sector. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

No recent news for VanEck Vectors Biotech ETF.


1 month-0.33% 3 years-4.52%
3 months-11.89% 5 years+10.54%
1 year-0.22% Since inception+21.07%
Data through 04/24/2018

Quote Details

Previous close$116.65
Open day’s range114.43 – 116.97
Net asset value (NAV)116.87 (04/23/2018)
Daily volume19,873
Average volume (3 months)47,497
Data as of 2:45pm ET, 04/24/2018

Peer Comparisonvs. Health ETFs

Performance 5-yr return+10.54%+14.29%
Expense Gross exp ratio0.39%1.30%
Risk 5 year sharpe ratio0.680.92
Net assets$438.7M$3.0B
Average market cap$33.9B$10.0B
Average P/E25.622.2
Dividend / Share--0.30%


XLV Health Care Select Sector SPDR® Fund
FHLC Fidelity® MSCI Health Care Index ETF
VHT Vanguard Health Care Index Fund ETF Shar...


Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
AMGN Amgen11.09%
GILD Gilead Sciences10.62%
CELG Celgene7.35%
SHPG Shire5.97%
AGN Allergan5.67%
BIIB Biogen5.38%
VRTX Vertex Pharmaceuticals Inc4.92%
REGN Regeneron Pharmaceuticals4.78%
ILMN Illumina Inc4.59%
IQV Iqvia Holdings Inc4.53%